MGFA has partnered with Bionews to feature the Myasthenia Gravis News feed on our website, providing the community with research updates, disease management insights, and relevant news. All content is original and produced by Bionews’ editorial staff, and perspectives from patients and caregivers. Information is not meant to replace or provide medical advice.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- Zilbrysq autoinjector found safe, effective in trials for use in gMG
by Marisa Wexler, MS on April 23, 2026 at 2:45 pmAn investigational autoinjector device for administering Zilbrysq (zilucoplan), an approved therapy for generalized myasthenia gravis (gMG), is a safe and effective option for individuals now using the currently available prefilled syringe, according to new data from two clinical trials. Users were “highly satisfied” with the Zilbrysq autoinjector and generally preferred it over the prefilled syringe, The post Zilbrysq autoinjector found safe, effective in trials for use in gMG appeared first on Myasthenia Gravis News.
- Dieting to be in better shape, not to have a perfect shape
by Sarah Bendiff on April 23, 2026 at 2:00 pmOne of the first things that tends to happen when you stop being physically active is you gain weight. It’s not automatic for everyone, but I know many curvy beauties will relate to this. There are some bodies that seem obsessed about storing fat, as if it would help them survive the end of the The post Dieting to be in better shape, not to have a perfect shape appeared first on Myasthenia Gravis News.
- Mental health challenges are often an invisible aspect of MG
by Mark Harrington on April 22, 2026 at 2:00 pmI like to think of myself as a strong individual. Even before myasthenia gravis (MG) entered my life, I had, like most people, faced my share of challenges: the usual relationship issues, loss of loved ones, and so on. Unlike most, I underwent two years of diagnosis, surgery, and post-operative recovery from brain cancer. This The post Mental health challenges are often an invisible aspect of MG appeared first on Myasthenia Gravis News.
- Myasthenia gravis diagnosis and testing
by Lila Levinson, PhD on April 22, 2026 at 9:00 amGetting a correct diagnosis of the rare autoimmune disease myasthenia gravis (MG) can be challenging, because its symptoms — typically muscle weakness and fatigue — are nonspecific and can be caused by many other disorders. The post Myasthenia gravis diagnosis and testing appeared first on Myasthenia Gravis News.
- New drug cemdisiran may offer gMG symptom relief with 4 doses a year
by Marisa Wexler, MS on April 21, 2026 at 12:00 pmCemdisiran, an experimental therapy given by injection under the skin every three months, was shown to significantly and sustainably ease symptoms of generalized myasthenia gravis (gMG) in a global, late-stage clinical trial called NIMBLE. In addition to suggesting that cemdisiran is an effective gMG treatment, the trial results provided valuable insight into the underlying biology The post New drug cemdisiran may offer gMG symptom relief with 4 doses a year appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.